• Inspira Technologies outlined strategy built around three tracks: scaling Additively Manufactured Electronics (AME) sales, developing quantum computing connectivity products for dilution cryostats, monetizing medical assets to raise non-dilutive capital.
• Quantum plan targets cryogenic wiring constraints with monolithic interconnect architecture; joint development with Qarakal Quantum intended to validate system-level performance, with additional collaborations expected in coming weeks.
• AME business set to drive near-term revenue ramp via system sales, consumables, service; management targets faster cash collection, higher recurring revenue, better gross margin.
• Medical unit repositioned for potential asset sales; management targets term sheet or definitive framework by end of Q3 2026, with burn-rate reduction to preserve capital during process.
• Shareholders backed name change to QTREX Quantum Ltd.; company also terminated ATM and SEPA facilities in March 2026 to simplify capital structure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspira Technologies OXY BHN Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605110731PRIMZONEFULLFEED9717253) on May 11, 2026, and is solely responsible for the information contained therein.